About
Technology
Issues
FAQ
Links
Official Page
KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.